Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma [NA]

View source ↗

Summary

Medtronic's study evaluating embolization of the middle meningeal artery with the ONYX liquid embolic system for subacute and chronic subdural hematoma has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONYX Liquid Embolic System

Snippet

Sponsor: Medtronic Neurovascular Clinical Affairs | Conditions: Subdural Hematoma | NA | Status: COMPLETED